BridgeMD
New treatment option for Healthy
Official title Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy
ClinicalTrials.gov ID: NCT07122739
What this study is testing
- What it's testing
- This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the prefrontal cortex and the hippocampus.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18-50
- No history of psychiatric disorders or neurological disorders affecting the central nervous system.
- Are not currently taking psychoactive medication or drugs of abuse.
- Must be eligible to enter an MRI (i.e., no permanent metal or medical implants)
- Normal color vision
You likely can't join if
- Pregnancy (female participants)
- Outside of age range
- History of psychiatric or neurological disease
- Currently taking psychoactive medication or drugs of abuse
- Color blindness
- Primary left-handedness
See the full eligibility criteria
- Adults aged 18-50
- No history of psychiatric disorders or neurological disorders affecting the central nervous system.
- Are not currently taking psychoactive medication or drugs of abuse.
- Must be eligible to enter an MRI (i.e., no permanent metal or medical implants)
- Normal color vision
- Right-handed
- Full reading and writing English comprehension
- Must exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
- Must be able to provide informed consent
- Pregnancy (female participants)
- Outside of age range
- History of psychiatric or neurological disease
- Currently taking psychoactive medication or drugs of abuse
- Color blindness
- Primary left-handedness
- Less than full reading and writing English comprehension
- Do not exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
- Refusing to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Princeton, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Princeton, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.